The A2aR adenosine receptor controls cytokine production in iNKT cells - Test2 - elhamkhani - TriplyDB

The A2aR adenosine receptor controls cytokine production in iNKT cells

The A2aR adenosine receptor controls cytokine production in iNKT cells

http://www.wikidata.org/entity/Q34257834

about

Turned on by danger: activation of CD1d-restricted invariant natural killer T cells A2aR antagonists: Next generation checkpoint blockade for cancer immunotherapy Extracellular ubiquitin: immune modulator and endogenous opponent of damage-associated molecular pattern molecules NOX2 Activation of Natural Killer T Cells Is Blocked by the Adenosine A2A Receptor to Inhibit Lung Ischemia-Reperfusion Injury The immunosuppressive role of adenosine A2A receptors in ischemia reperfusion injury and islet transplantation.Immunological alterations mediated by adenosine during host-microbial interactions Adenosine A(2A) receptors promote collagen production by a Fli1- and CTGF-mediated mechanism.A(2A) adenosine receptors are differentially modulated by pharmacological treatments in rheumatoid arthritis patients and their stimulation ameliorates adjuvant-induced arthritis in rats.Beyond hydroxyurea: new and old drugs in the pipeline for sickle cell disease.Targeting the hypoxia-adenosinergic signaling pathway to improve the adoptive immunotherapy of cancer.Activation of invariant NK T cells in periodontitis lesions.Pulmonary natural killer T cells play an essential role in mediating hyperoxic acute lung injury.Adipose tissue invariant NKT cells protect against diet-induced obesity and metabolic disorder through regulatory cytokine production.Production of adenosine by ectonucleotidases: a key factor in tumor immunoescape.Purinergic signalling and immune cells.Adenosine regulation of the immune response initiated by ischemia reperfusion injury.Targeting A2 adenosine receptors in cancer.Extracellular adenosine controls NKT-cell-dependent hepatitis induction The antiviral drug tenofovir, an inhibitor of Pannexin-1-mediated ATP release, prevents liver and skin fibrosis by downregulating adenosine levels in the liver and skin.Early immune anergy towards recall antigens and mitogens in patients at onset of septic shock.Harnessing the Power of Invariant Natural Killer T Cells in Cancer Immunotherapy.Developing new pharmacotherapeutic approaches to treating sickle-cell disease.Treatment with Adenosine Receptor Agonist Ameliorates Pain Induced by Acute and Chronic Inflammation.Induction of antiinflammatory purinergic signaling in activated human iNKT cells

P2860

Q26825059-28CE7C2E-34AC-45B5-8FA8-EB5BAFDB40A3 Q28087576-62819E5A-777F-4A54-9797-502D7BE04851 Q28289847-ED6FF16C-53F2-458F-8418-B984CCCA8CB1 Q30277768-2CDD4A51-F792-4E2D-91A5-90CEDBEB1C90 Q30409961-FF00988A-B08B-4E3D-BD15-84F2D8A35F98 Q30426800-60C46DBA-8AED-42E1-A7FD-17EFE8390CC6 Q33765783-EDD294F6-89B7-479A-8240-182AE21779CB Q34552239-B3FECA66-F9C1-4C25-92A9-45C1806325F5 Q36596855-EC58FB29-5B3C-4B0B-B232-599EEB07DDDA Q36620552-8480F1A6-2174-4BE3-86CF-C6E20298CC61 Q36750852-51EE0CFB-16DA-467F-AAD3-ACE35F6775B7 Q36999844-C65F11F8-EBC0-4C72-B692-FD71ED3D1B02 Q37191048-EA556DC2-6044-4678-93FE-4B9DBDDE64E8 Q38058320-84FE279C-6067-4115-83CC-1567DDC8B1BA Q38263455-84CAB621-2D78-4ED8-845B-B975E813BDB2 Q38490402-8A59F5B5-00A2-496F-ABCF-FC4100BC842F Q39125149-1D0B0E89-6207-40AE-8C43-AFCC220FB7E8 Q41675213-4ECA1B9C-CBA3-4F78-AEF5-B04CDD99BE00 Q46837128-6434BDF1-7284-414E-BA04-25DB134BBD68 Q49259114-0F55C963-58B2-4B1E-BCDA-6C19CC35E146 Q50075685-AE54A00E-1EA7-4A30-A1BA-6E4889118543 Q50207951-B225CE67-3CB0-448D-9DDD-4A41A72971F9 Q53096946-28852368-AA24-4077-BCB8-053F45C9309D Q57444218-CFB19E06-AC0E-4E95-B63E-B372EFAF0096

P2860

The A2aR adenosine receptor controls cytokine production in iNKT cells

http://www.wikidata.org/entity/Q34257834

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

The A2aR adenosine receptor controls cytokine production in iNKT cells

@ast

The A2aR adenosine receptor controls cytokine production in iNKT cells

@en

The A2aR adenosine receptor controls cytokine production in iNKT cells

@nl

type

label

The A2aR adenosine receptor controls cytokine production in iNKT cells

@ast

The A2aR adenosine receptor controls cytokine production in iNKT cells

@en

The A2aR adenosine receptor controls cytokine production in iNKT cells

@nl

prefLabel

The A2aR adenosine receptor controls cytokine production in iNKT cells

@ast

The A2aR adenosine receptor controls cytokine production in iNKT cells

@en

The A2aR adenosine receptor controls cytokine production in iNKT cells

@nl

P1433

Q34257834-9C1C1083-8795-407D-9049-DE750F95CD5D

P1476

Q34257834-CCF396A2-63E0-45AB-897F-A1626C1D64FB

P2093

Q34257834-11210CAF-B535-445A-A4CB-C641A56C3826

Q34257834-25E47306-CDD2-4AC6-9C92-FBDE67B02921

Q34257834-3CB66958-BE96-4D25-AA07-A077A9E98A9A

Q34257834-5B00A946-1992-4CED-825C-202CCFBB4456

Q34257834-792E51F4-0023-4202-AEB8-43B2D15C12E1

Q34257834-C14E2C4A-2A12-479C-8FB4-5AA9A8C080EC

Q34257834-DABEFBBE-A867-46CC-BA56-7624E0F8FBD7

P2860

Q34257834-02E971F8-0897-428E-8C90-1F0372C90165

Q34257834-12F01304-95D8-447E-93E6-A15BB8BC6117

Q34257834-1958E720-BABF-4324-8D0C-2EBD39A18CC5

Q34257834-23FBDF69-3C53-4C36-B001-45741FBFCFFB

Q34257834-3203A54B-1853-4B00-8CF6-DE8E3246CA07

Q34257834-3A321C10-518D-4779-9E43-AC67C4EBA25A

Q34257834-465F394F-C41A-40A9-AC2F-A3DF8B2E8739

Q34257834-5056491A-6D62-43D8-8445-50C42DF025B3

Q34257834-621E0CAA-D30D-4AAA-8BE2-EFE284E99912

Q34257834-6A765B53-C879-4332-8DC6-B1E9E17FC476

P304

Q34257834-5A98AA4A-4A3D-4AC9-861F-CFF482771E6D

P31

Q34257834-61128869-C0A8-4758-88B1-01931D014393

P356

Q34257834-BFD019F4-2A9E-41F5-BEB6-F6B9676513B1

P407

Q34257834-BAE093C4-2ACD-4935-9F6D-97857112A3AE

P433

Q34257834-1A7771B7-76B2-4D54-ACE3-2BD06646AC79

P478

Q34257834-BCBA22A0-E385-4850-93B5-6636A9F88E3A

P577

Q34257834-36B2FB37-0D27-4423-93C9-4F415F7795FE

P5875

Q34257834-F43AB2C9-FAB4-4969-989C-35B6BEFA24D4

P698

Q34257834-349118D7-EBE5-43D3-83BF-F17658992828

P932

Q34257834-0BC7646D-C0EA-4AFD-82A1-CED8FC9E6B46

P356

P1433

European Journal of Immunology

P1476

The A2aR adenosine receptor controls cytokine production in iNKT cells

@en

P2093

Akio Ohta

http://www.w3.org/2001/XMLSchema#string

Lydia Lynch

http://www.w3.org/2001/XMLSchema#string

Mark A Exley

http://www.w3.org/2001/XMLSchema#string

Michael Nowak

http://www.w3.org/2001/XMLSchema#string

Michail Sitkovsky

http://www.w3.org/2001/XMLSchema#string

Simon Yue

http://www.w3.org/2001/XMLSchema#string

Steven P Balk

http://www.w3.org/2001/XMLSchema#string

P2860

A2A receptors in inflammation and injury: lessons learned from transgenic animals

International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors

Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression.

Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor

Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection.

The A2B adenosine receptor impairs the maturation and immunogenicity of dendritic cells

A2A adenosine receptor induction inhibits IFN-gamma production in murine CD4+ T cells.

Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation.

Natural killer T cell dysfunction in CD39-null mice protects against concanavalin A-induced hepatitis

Structure and function of adenosine receptors and their genes.

P304

682-687

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/EJI.200939897

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

40

http://www.w3.org/2001/XMLSchema#string

P577

2010-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40806249

http://www.w3.org/2001/XMLSchema#string

P698

20039304

http://www.w3.org/2001/XMLSchema#string

P932

2967447

http://www.w3.org/2001/XMLSchema#string